COLOPLAST SP.ADR 1/10 DK1 (CBH) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.162x

Based on the latest financial reports, COLOPLAST SP.ADR 1/10 DK1 (CBH) has a cash flow conversion efficiency ratio of 0.162x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.23 Billion ≈ $2.61 Billion USD) by net assets (€13.80 Billion ≈ $16.14 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CBH equity financing ratio to measure how much of total assets are equity-financed.

COLOPLAST SP.ADR 1/10 DK1 - Cash Flow Conversion Efficiency Trend (2021–2024)

This chart illustrates how COLOPLAST SP.ADR 1/10 DK1's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of COLOPLAST SP.ADR 1/10 DK1 to evaluate the quality of earnings relative to operating cash generation.

COLOPLAST SP.ADR 1/10 DK1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of COLOPLAST SP.ADR 1/10 DK1 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Samsung Heavy Industries
KO:010140
-0.018x
LLOYDS METALS AND ENERGY LTD.
NSE:LLOYDSME
-0.114x
Smith & Nephew SNATS Inc
NYSE:SNN
0.168x
Cipla Limited
NSE:CIPLA
0.041x
SK Telecom Co Ltd
KO:017670
0.085x
Zhejiang Satellite Petrochemical Co Ltd
SHE:002648
0.092x
GRAB HOLDINGS LTD CL.A
F:A6I
0.010x
Guardant Health Inc
NASDAQ:GH
0.362x

Annual Cash Flow Conversion Efficiency for COLOPLAST SP.ADR 1/10 DK1 (2021–2024)

The table below shows the annual cash flow conversion efficiency of COLOPLAST SP.ADR 1/10 DK1 from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see CBH company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-09-30 €17.94 Billion
≈ $20.98 Billion
€2.77 Billion
≈ $3.23 Billion
0.154x -36.89%
2023-09-30 €17.30 Billion
≈ $20.22 Billion
€4.23 Billion
≈ $4.94 Billion
0.244x -60.27%
2022-09-30 €8.29 Billion
≈ $9.69 Billion
€5.10 Billion
≈ $5.96 Billion
0.615x -5.05%
2021-09-30 €8.17 Billion
≈ $9.55 Billion
€5.29 Billion
≈ $6.18 Billion
0.648x --

About COLOPLAST SP.ADR 1/10 DK1

F:CBH Germany Medical Instruments & Supplies
Market Cap
$13.33 Billion
€11.41 Billion EUR
Market Cap Rank
#1867 Global
#389 in Germany
Share Price
€5.50
Change (1 day)
-1.79%
52-Week Range
€5.50 - €9.50
All Time High
€15.64
About

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more